Health research funded under the Seventh Framework Programme for research and technological development (FP7) is a significant driver for the improvement of the health of European citizens and of global health, and for the competitiveness of European health-related industries and businesses.
EU funding in 2009
The programme funds research projects focusing on a variety of topics including, but not limited to: public health; infectious diseases; large-scale data gathering and systems biology; biotechnology, tools and technologies. In addition, other large-scale, ambitious efforts are also in progress.
The Innovative Medicines Initiative (IMI) Joint Undertaking is the largest public–private partnership in the area of medical research and reached autonomy in 2009. Jointly financed by the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), it aims to significantly improve the efficiency and effectiveness of the drug development process while securing the competitiveness of Europe’s pharmaceutical industry. More effective and safer innovative medicines will enable patients to obtain the most appropriate treatment.